Skip to main content

Animations

MJFF Publications

7881 - 7890 of 9038 Results
Title
Year
  • Year
  • 2023
  • 2020
  • 2017
  • 2019
  • 2019
  • 2020
  • 2023
  • 2024
  • 2024
  • 2013
  • Summary Details
    OPEN
    Title: Lifespan neurodegeneration of the human brain in multiple sclerosis
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.26464
    Citation Count: 26
  • Outcomes of genetic test disclosure and genetic counseling in a large Parkinson's disease research study
    2020
    Summary Details
    RESTRICTED
    Title: Outcomes of genetic test disclosure and genetic counseling in a large Parkinson's disease research study
    Journal Name: Journal of Genetic Counseling
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/jgc4.1366
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12553
    Citation Count: 213
  • Summary Details
    OPEN
    Title: Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mdc3.12851
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Earlier Dopaminergic Treatment in Parkinson's Disease Is Not Associated With Improved Outcomes
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12724
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Abstracts
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/mdc3.12905
    Citation Count: 4
  • Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodies
    2023
    Summary Details
    OPEN
    Title: Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad391
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders
    Journal Name: Bioengineering & Translational Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/btm2.10665
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐Berbers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29735
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.3861
    Citation Count: 368
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.